Bicarbonate as a predictor of successful insulin transition in critically ill patients with diabetic ketoacidosis: A retrospective cohort study.
anion gap
critical care
diabetic ketoacidosis
insulin
intravenous injection
Journal
Pharmacotherapy
ISSN: 1875-9114
Titre abrégé: Pharmacotherapy
Pays: United States
ID NLM: 8111305
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
revised:
23
03
2023
received:
25
11
2022
accepted:
28
03
2023
medline:
22
6
2023
pubmed:
3
5
2023
entrez:
3
5
2023
Statut:
ppublish
Résumé
Treatment of diabetic ketoacidosis with intravenous insulin is effective but resource intensive. Treatment guidelines recommend transitioning to subcutaneous insulin when the anion gap closes, but transition failures due to recrudescent ketoacidosis are common despite adherence to treatment protocols following such guidance. The primary objective of our study was to evaluate the ability of serum bicarbonate levels of ≤16 mEq/L to predict intravenous to subcutaneous transition failures among those with a normal anion gap at the time of transition. This retrospective cohort study evaluated critically ill adult patients with a primary diagnosis of diabetic ketoacidosis. Historical patient data were obtained by manual chart review. The primary outcome was transition failure, defined as the re-initiation of intravenous insulin within 24 h of transitioning to subcutaneous insulin. Odds ratios were calculated using generalized estimating equations with a logit link and weighted by standardized inverse probability weights to assess the predictive value of serum bicarbonate levels. The primary analysis included 93 patients with a total of 118 distinct transitions. In the adjusted analysis, patients whose anion gap had normalized but had a serum bicarbonate of ≤16 mEq/L were significantly more likely to experience a transition failure (odds ratio = 4.74, 95% confidence interval: 1.24-18.1, p = 0.02). The results of the unadjusted analysis were similar. In patients with a normal anion gap at the time of insulin transition, serum bicarbonate levels of ≤16 mEq/L were associated with significantly increased odds of transition failure.
Sections du résumé
BACKGROUND
Treatment of diabetic ketoacidosis with intravenous insulin is effective but resource intensive. Treatment guidelines recommend transitioning to subcutaneous insulin when the anion gap closes, but transition failures due to recrudescent ketoacidosis are common despite adherence to treatment protocols following such guidance.
STUDY OBJECTIVE
The primary objective of our study was to evaluate the ability of serum bicarbonate levels of ≤16 mEq/L to predict intravenous to subcutaneous transition failures among those with a normal anion gap at the time of transition.
DESIGN AND SETTING
This retrospective cohort study evaluated critically ill adult patients with a primary diagnosis of diabetic ketoacidosis. Historical patient data were obtained by manual chart review. The primary outcome was transition failure, defined as the re-initiation of intravenous insulin within 24 h of transitioning to subcutaneous insulin. Odds ratios were calculated using generalized estimating equations with a logit link and weighted by standardized inverse probability weights to assess the predictive value of serum bicarbonate levels.
MAIN RESULTS
The primary analysis included 93 patients with a total of 118 distinct transitions. In the adjusted analysis, patients whose anion gap had normalized but had a serum bicarbonate of ≤16 mEq/L were significantly more likely to experience a transition failure (odds ratio = 4.74, 95% confidence interval: 1.24-18.1, p = 0.02). The results of the unadjusted analysis were similar.
CONCLUSIONS
In patients with a normal anion gap at the time of insulin transition, serum bicarbonate levels of ≤16 mEq/L were associated with significantly increased odds of transition failure.
Substances chimiques
Insulin
0
Bicarbonates
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
485-493Informations de copyright
© 2023 Pharmacotherapy Publications, Inc.
Références
Powers AC, Niswender KD, Rickels MR. Diabetes mellitus: management and therapies. In: Jameson J, Fauci AS, Kasper DL, et al., eds. Harrison's Principles of Internal Medicine. 20th ed. McGraw-Hill; 2020. https://accesspharmacy.mhmedical.com/content.aspx?bookid=2129§ionid=192288412
Trujillo J, Haines S. Diabetes mellitus. In: Dipiro JT, Yee GC, Posey L, et al., eds. Pharmacotherapy: A Pathophysiologic Approach. 11th ed. McGraw-Hill; 2020. https://accesspharmacy.mhmedical.com/content.aspx?bookid=2577§ionid=228901946
Westerberg DP. Diabetic ketoacidosis: evaluation and treatment. Am Fam Physician. 2013;87(5):337-346.
Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32:1335-1343. doi:10.2337/dc09-9032
French EK, Donihi AC, Korytkowski MT. Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ. 2019;365:1114. doi:10.1136/bmj.l1114
Desai D, Mehta D, Mathias P, et al. Health care utilization and burden of diabetic ketoacidosis in the U.S. over the past decade: a nationwide analysis. Diabetes Care. 2018;41(8):1631-1638. doi:10.2337/dc17-1379
Lyerla R, Johnson-Rabbett B, Shakally A, Magar R, Alameddine H, Fish L. Recurrent DKA results in high societal costs-a retrospective study identifying social predictors of recurrence for potential future intervention. Clin Diabetes Endocrinol. 2021;7(1):13. doi:10.1186/s40842-021-00127-6
Benoit SR, Zhang Y, Geiss LS, et al. Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality-United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2018;67:362-365.
Paulson WD. Anion gap-bicarbonate relation in diabetic ketoacidosis. Am J Med. 1986;81(6):995-1000. doi:10.1016/0002-9343(86)90394-3
Kraut JA, Nagami GT. The serum anion gap in the evaluation of acid-base disorders: what are its limitations and can its effectiveness be improved? Clin J Am Soc Nephrol. 2013;8(11):2018-2024. doi:10.2215/CJN.04040413
Chawla LS, Shih S, Davison D, Junker C, Seneff MG. Anion gap, anion gap corrected for albumin, base deficit and unmeasured anions in critically ill patients: implications on the assessment of metabolic acidosis and the diagnosis of hyperlactatemia. BMC Emerg Med. 2008;8:18. doi:10.1186/1471-227X-8-18
Avanzini F, Marelli G, Donzelli W, et al. Transition from intravenous to subcutaneous insulin: effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome. Diabetes Care. 2011;34(7):1445-1450. doi:10.2337/dc10-2023
Kreider KE, Lien LF. Transitioning safely from intravenous to subcutaneous insulin. Curr Diab Rep. 2015;15(5):23. doi:10.1007/s11892-015-0595-4
Feldman M, Soni NJ, Dickson B. Use of sodium concentration and anion gap to improve correlation between serum chloride and bicarbonate concentrations. J Clin Lab Anal. 2006;20(4):154-159. doi:10.1002/jcla.20124
Adrogué HJ, Wilson H, Boyd AE, et al. Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med. 1982;307(26):1603-1610. doi:10.1056/NEJM198212233072603
Forni LG, McKinnon W, Lord GA, et al. Circulating anions usually associated with the Krebs cycle in patients with metabolic acidosis. Crit Care. 2005;9(5):R591-R595. doi:10.1186/cc3806
Zhou VL, Shofer FS, Desai NG, et al. Predictors of short intensive care unit stay for patients with diabetic ketoacidosis using a novel emergency department-based resuscitation and critical care unit. J Emerg Med. 2019;56(2):127-134. doi:10.1016/j.jemermed.2018.09.048
Gauntt J, Vaidyanathan P, Basu S. Utilizing serum bicarbonate instead of venous pH to transition from intravenous to subcutaneous insulin shortens the duration of insulin infusion in pediatric diabetic ketoacidosis. J Pediatr Endocrinol Metab. 2019;32(1):11-17. doi:10.1515/jpem-2018-0394
Edholm K, Lappé K, Kukhareva P, et al. Reducing diabetic ketoacidosis intensive care unit admissions through an electronic health record-driven, standardized care pathway. J Healthc Qual. 2020;42(5):e66-e74. doi:10.1097/JHQ.0000000000000247
Adrogué HJ, Eknoyan G, Suki WK. Diabetic ketoacidosis: role of the kidney in the acid-base homeostasis re-evaluated. Kidney Int. 1984;25(4):591-598. doi:10.1038/ki.1984.62
Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care. 2013;17(1):204. doi:10.1186/cc11454
Laine L, Barkun AN, Saltzman JR, et al. ACG clinical guideline: upper gastrointestinal and ulcer bleeding. Am J Gastroenterol. 2021;116(5):899-917. doi:10.14309/ajg.0000000000001245
Robins JM, Hernán MÁ, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550-560. doi:10.1097/00001648-200009000-00011
Elze MC, Gregson J, Baber U, et al. Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies. J Am Coll Cardiol. 2017;69(3):345-357. doi:10.1016/j.jacc.2016.10.060
Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661-3679. doi:10.1002/sim.6607
Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6):656-664. doi:10.1093/aje/kwn164
Højsgaard S, Halekoh U, Yan J. The R package geepack for generalized estimating equations. J Stat Softw. 2006;15(2):1-11. doi:10.18637/jss.v015.i02
Lin DY, Psaty BM, Kronmal RA. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics. 1998;54(3):948-963.
Newton CA, Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences. Arch Intern Med. 2004;164(17):1925. doi:10.1001/archinte.164.17.1925